Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reveal a generally positive outlook. Despite a slight dip in Q2, growth is expected in the latter half of the year, with strong EBITDA and cash flow. Strategic investments and new program ramp-ups are promising, and the Health segment shows long-term potential. The company maintains its CapEx plan, indicating confidence in future growth. Management's optimism, coupled with robust financial health and strategic focus on high-return projects, suggest a positive stock price movement.
Revenue First quarter revenue was $4.4 billion, up 4% year-on-year. The increase was driven by robust growth in the Intelligence and Digital and Homeland segments, as well as accelerated mission execution for innovative products and solutions.
Adjusted EBITDA Adjusted EBITDA was $614 million for the first quarter, up 2% year-over-year, with an adjusted EBITDA margin of 14%. This was supported by prudent cost management, excellent award and incentive fee performance, and a $15 million insurance reimbursement for previously recorded legal expenses.
Non-GAAP Diluted EPS Non-GAAP diluted EPS grew 5% to $3.13, driven by higher adjusted EBITDA, lower share count, and a lower tax rate.
Intel and Digital Revenues Intel and Digital revenues increased 7% year-over-year, with 6% coming organically. Growth was driven by recent contract awards and increased volumes for intelligence community mission support, as well as $22 million from the acquisition of Kudu Dynamics.
Homeland Revenues Homeland revenues increased 6% year-over-year due to surging demand for energy infrastructure engineering services and domestic and international air traffic control systems.
Defense Revenues Defense revenues were $883 million, up slightly compared to the prior year quarter. Growth in integrated air defense systems offset the wind down of some airborne surveillance programs.
Operating Cash Flow Operating cash flow was $301 million, with free cash flow at $270 million. This was attributed to strong EBITDA generation, proactive collections, and disciplined working capital management.
Debt and Leverage The company ended the quarter with $6.3 billion of debt, $457 million in cash and cash equivalents, and a gross leverage ratio of 2.6x. This reflects robust cash generation and disciplined financial management.
Small Cruise Missile (AGM-190A): Leidos is accelerating production and working on derivatives of the AGM-190A, with potential production runs of thousands within this decade.
Seahawk MUSV: The Seahawk MUSV has been operationally deployed as part of the Theodore Roosevelt Carrier Strike Group, marking it as the U.S. Navy's first and only medium unmanned surface vehicle to reach this level of deployment.
AirShield Counter UAS Technology: Leidos is advancing discussions to scale production of its AirShield high-power microwave counter UAS technology, which outperforms competitors in range and lethality.
ALPS Passive Sensing System: Leidos has begun serial production of ALPS under a $2.2 billion ABADS-MD contract, providing wide-area awareness at reduced costs.
My Service Treatment Record: Leidos is developing an AI-driven tool to automate medical record transfers for service members, streamlining a previously manual process.
Military OneSource Award: Leidos secured a $456 million award to provide various support services to military personnel and their families, enhancing its position in the managed health market.
Energy Infrastructure Expansion: Leidos' acquisition of Entrust has led to new opportunities, including a detailed design project for Canada's largest battery electrical storage facility and a refreshed $10 billion order pipeline.
Cybersecurity Market: The acquisition of Kudu has expanded Leidos' cyber capabilities, with a current pipeline valued at $24 billion, a 21% increase since the acquisition.
AI Integration: Leidos is leveraging AI to enhance operational efficiency, compressing solution delivery times and enabling faster, more scalable operations.
Cash Flow Management: Leidos generated $301 million in operating cash flow in Q1 2026, showcasing strong financial management and operational efficiency.
NorthStar 2030 Growth Strategy: Leidos is focusing on five growth pillars: defense tech, managed health, digital infrastructure and cyber, energy resilience, and mission software.
Entrust Acquisition: The acquisition has been integrated ahead of schedule, contributing to financial and operational synergies, and expanding Leidos' energy infrastructure capabilities.
Joint Venture with Analogic: Leidos announced a joint venture to strengthen homeland defense, creating a focused leader in the global market.
Venture Investment in Federal Technology: Leidos committed $100 million to a private equity firm to gain early access to high-growth disruptors in AI, advanced cyber, and autonomy.
Defense Technology: Potential delays in framework agreements and production scaling for advanced products like SCM, MUSVs, and AirShield could impact revenue and operational timelines. Additionally, reliance on large-scale defense contracts poses risks if government priorities or budgets shift.
Health Sector: Dependence on government contracts like Military OneSource and My Service Treatment Record Pilot creates vulnerability to policy changes or funding cuts. Integration of AI-driven tools and digital systems may face technical or operational challenges.
Acquisitions and Integration: The rapid integration of acquisitions like Entrust and Kudu may encounter unforeseen operational or cultural challenges, potentially delaying synergies and financial benefits. Over-reliance on acquisitions for growth could strain resources.
AI and Technology Implementation: While AI is seen as an accelerant, its implementation across various sectors may face challenges such as regulatory compliance, data security, and customer trust. Over-reliance on AI could expose the company to risks if technology fails or underperforms.
Economic and Market Conditions: Dependence on government and defense spending makes the company vulnerable to economic downturns, budget cuts, or shifts in government priorities. Additionally, competition in high-growth markets like cyber and energy resilience could pressure margins.
Supply Chain and Operational Efficiency: Scaling production for defense and energy projects may face supply chain disruptions or inefficiencies, impacting delivery timelines and costs.
Revenue Guidance: Leidos has raised its 2026 revenue guidance by $500 million to a new range of $18 billion to $18.4 billion, reflecting the impact of the Entrust acquisition.
Earnings Guidance: Non-GAAP diluted EPS guidance has been increased by $0.05, yielding a range of $12.10 to $12.50 for 2026.
Operating Cash Flow Guidance: Operating cash flow guidance has been raised by $50 million to approximately $1.8 billion for 2026.
Entrust Acquisition Impact: The Entrust acquisition is expected to be accretive to non-GAAP EPS and cash in 2026, with substantially more accretion anticipated in 2027 and beyond.
Defense Technology Growth: Leidos anticipates strong demand across its defense technology portfolio, with a pipeline of $8 billion in the next 12 months and production runs of thousands of products like the AGM-190A small cruise missile expected this decade.
Health Segment Growth: Sustainable growth is expected in the health segment, supported by new awards like the $456 million Military OneSource program and the My Service Treatment Record pilot program.
Cybersecurity and AI: The cybersecurity pipeline has grown to $24 billion, a 21% increase since the Kudu acquisition, with AI technology accelerating delivery and operations.
Energy Infrastructure Expansion: The Entrust acquisition has expanded the energy infrastructure pipeline to $10 billion, representing 230% growth post-close.
AI Integration: Leidos is leveraging AI to enhance efficiency and scalability across its operations, positioning itself as a leader in AI-enabled mission systems.
Shareholder Return Plan: We were also able to repurchase $200 million of stock in the open market as part of our balanced capital deployment strategy.
Shareholder Return Plan: We were also able to repurchase $200 million of stock in the open market as part of our balanced capital deployment strategy.
The earnings call summary and Q&A reveal a generally positive outlook. Despite a slight dip in Q2, growth is expected in the latter half of the year, with strong EBITDA and cash flow. Strategic investments and new program ramp-ups are promising, and the Health segment shows long-term potential. The company maintains its CapEx plan, indicating confidence in future growth. Management's optimism, coupled with robust financial health and strategic focus on high-return projects, suggest a positive stock price movement.
The earnings call reveals strong financial performance, with increased margins across segments and raised guidance for EBITDA and EPS. The Q&A highlights strategic investments and a strong growth pipeline, although some management responses lack clarity. The reaffirmation of revenue guidance and increased profitability expectations, alongside strategic initiatives in defense and infrastructure, suggest a positive outlook. Despite concerns over AI and CapEx, the overall sentiment is positive, with potential upside from new contracts and programs.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.